Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01041885
What this trial is testing

INSTRUCT for Repair of Knee Cartilage Defects

Who this might be right for
Articular Cartilage Lesion of the Knee
CellCoTec B.V. 40
Testing effectiveness (Phase 2)Study completedNCT01286649
What this trial is testing

Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
TrichoScience Innovations, Inc. 19
Testing effectiveness (Phase 2)WithdrawnNCT05222438
What this trial is testing

Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant

Who this might be right for
Relapsed Diffuse Large B-cell Lymphoma
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)UnknownNCT00465478
What this trial is testing

Autologous Bone Marrow Mononuclear Cells Transplantation in Treating Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Shandong University 200
Early research (Phase 1)Study completedNCT00717184
What this trial is testing

A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Metastatic Nasopharyngeal
National University Hospital, Singapore
Testing effectiveness (Phase 2)Study completedNCT00046852
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma

Who this might be right for
InfectionMultiple Myeloma and Plasma Cell Neoplasm
University of Maryland, Baltimore
Large-scale testing (Phase 3)UnknownNCT05071638
What this trial is testing

Effect of Autologous Cord Blood Mononuclear Cells for Treatment of Bronchopulmonary Dysplasia in Extremely Preterm Neonates

Who this might be right for
BPD
Guangdong Women and Children Hospital 76
Not applicableEnded earlyNCT02307448
What this trial is testing

Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Non-Healing Wounds

Who this might be right for
Foot Ulcer ChronicSkin Ulcer Venous Stasis ChronicPressure Ulcer
ACR Biologics, LLC 80
Testing effectiveness (Phase 2)WithdrawnNCT05966233
What this trial is testing

R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma RefractoryDiffuse Large B-cell Lymphoma Recurrent
Fondazione Italiana Linfomi - ETS
Early research (Phase 1)Study completedNCT01916577
What this trial is testing

Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation

Who this might be right for
COPDCystic FibrosisPulmonary Fibrosis
University of Colorado, Denver 15
Very early researchStudy completedNCT01957956
What this trial is testing

Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Giant Cell GlioblastomaGlioblastomaGliosarcoma
Mayo Clinic 21
Testing effectiveness (Phase 2)Study completedNCT01702831
What this trial is testing

Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

Who this might be right for
Multiple Myeloma
University Health Network, Toronto 78
Testing effectiveness (Phase 2)Study completedNCT01674439
What this trial is testing

Clinical Trial of Fat Grafts Supplemented With Adipose-derived Regenerative Cells

Who this might be right for
Craniofacial Microsomia
University of Sao Paulo 29
Early research (Phase 1)Active Not RecruitingNCT03016377
What this trial is testing

Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL

Who this might be right for
Acute Lymphoblastic LeukemiaImmune System DiseasesImmunoproliferative Disorders
UNC Lineberger Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT00720031
What this trial is testing

Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones

Who this might be right for
Immunotherapy
Nantes University Hospital 16
Early research (Phase 1)Looking for participantsNCT05402072
What this trial is testing

AMIC Compared With Microfracture for Focal Articular Cartilage Damage of the Hip

Who this might be right for
Hip ArthroscopyArticular Cartilage DefectMicrofractures
McMaster University 40
Not applicableStudy completedNCT05193877
What this trial is testing

Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis:Baghdad 2022

Who this might be right for
Treatment Complication
Global Stem Cell Center, Baghdad 60
Large-scale testing (Phase 3)Study completedNCT00114530
What this trial is testing

Scleroderma: Cyclophosphamide or Transplantation

Who this might be right for
Scleroderma, SystemicSclerosisAutoimmune Disease
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)Study completedNCT00225212
What this trial is testing

Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaDiffuse Large Cell LymphomaMantle Cell Lymphoma+3 more
Stanford University 35
Testing effectiveness (Phase 2)Study completedNCT00911365
What this trial is testing

Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
Yonsei University 27
Next Page